Ignite Creation Date:
2025-12-25 @ 2:35 AM
Ignite Modification Date:
2026-01-01 @ 3:34 AM
Study NCT ID:
NCT07076134
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-08-17
First Post:
2024-11-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Community-and Primary Care-based Intervention Linked With mObile Technology for HTN Control in Nepal
Sponsor:
Duke Kunshan University
Organization:
Study Overview
Official Title:
A Pilot Trial of a Community-and Primary Care-based Intervention Linked With mObile Technology for Hypertension Control in Nepal (CoPILOT Trial)
Status:
NOT_YET_RECRUITING
Status Verified Date:
2025-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CoPILOT
Brief Summary:
The clinical trial aims to evaluate whether a community and primary care-based intervention linked with mobile technology (CoPILOT) is acceptable, effective, cost-effective, sustainable, and scalable in improving hypertension (HTN) control among individuals aged 30 to 70 in Nepal. The primary research questions include:
Is the use of the application by Frontline Health Workers (FLHWs) and Female Community Health Volunteers (FCHVs) feasible and acceptable? Can FCHVs equipped with mHealth technology effectively increase the linkage of individuals with elevated blood pressure (BP) to health facilities? Does a mobile-based lifestyle intervention reduce or control BP? Can adherence to prescribed HTN treatments be improved among patients through this intervention?
Is the use of the application by Frontline Health Workers (FLHWs) and Female Community Health Volunteers (FCHVs) feasible and acceptable? Can FCHVs equipped with mHealth technology effectively increase the linkage of individuals with elevated blood pressure (BP) to health facilities? Does a mobile-based lifestyle intervention reduce or control BP? Can adherence to prescribed HTN treatments be improved among patients through this intervention?
Detailed Description:
The researcher will compare the intervention and control groups to assess changes in BP, quality of life (QoL), body mass index (BMI), medication adherence, and linkage to care.
Participants in the intervention group will:
Attend bi-monthly meetings conducted by FCHVs for BP measurement, facilitated through the mobile application.
Receive healthy lifestyle awareness guidance provided by FCHVs via the mobile app and supplemented with text message reminders.
Visit nearby health facilities for monthly follow up.
Participants in the intervention group will:
Attend bi-monthly meetings conducted by FCHVs for BP measurement, facilitated through the mobile application.
Receive healthy lifestyle awareness guidance provided by FCHVs via the mobile app and supplemented with text message reminders.
Visit nearby health facilities for monthly follow up.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| DGHI pilot grant | OTHER_GRANT | Duke Global Health Institute | View |